Call Us Now

ERBITUX (cetuximab)

Manufacturer : MER-MERCK LIMITED
Composition : CETUXIMAB-2MG/ML
Description : ERBITUX 5MG/20ML INJ
Route Of Administration : PARENTERAL
Pack : 1

Erbitux® is an epidermal growth factor receptor (EGFR) antagonist indicated for treatment of: Head and Neck Cancer and Colorectal Cancer.


Get In Touch

Get in touch with us at South Delhi Pharma (SDM), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:

3 + 15 =

Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada. DOSAGE FORMS AND STRENGTHS 100 mg/50 mL, single-use vial 200 mg/100 mL, single-use vial

Additional information

Weight 0.25 kg

Pharma Services and Drug Inquiries

Our Pharma Division deals only with the best, GMP certified generics and branded medication for the export market. All our products are supported by strict adherence to quality and analysis certification.

Please note for the minimum order for Exports is of US$ 300. All orders will be subject to courier charges and supplies are normally dispatched through internationally accredited courier services.

Complete the form below to receive the no-obligation price quote.


Note : We do not supply schedule-H (Example – narcotic drug or psychotropic drugs or anabolic steroids) and Anti- Abortion Drugs.


There are no reviews yet.

Be the first to review “ERBITUX (cetuximab)”

Your email address will not be published. Required fields are marked *